RIGL - Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats
2025-11-05 12:38:45 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call Transcript
- Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion
- Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout
- Rigel raises 2025 revenue guidance to $285M–$290M as commercial sales growth accelerates
- Rigel Pharmaceuticals GAAP EPS of $1.46 beats by $0.56, revenue of $69.46M beats by $7.58M